Frontlight ResearchEarly access
Trial site
Kota Kinabalu
- 6running trials
- 1closed trial
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Hidradenitis suppurativa2 trials
- Atopic dermatitis (eczema)1 trial
- Chronic myeloid leukaemia1 trial
- Immune thrombocytopenia (ITP)1 trial
- Myeloproliferative neoplasms1 trial
- Phase
- Phase 36 trials
- Phase 21 trial
- Status
- Active, not recruiting4 trials
- Recruiting2 trials
- Completed1 trial
- Lead sponsor
- Novartis Pharmaceuticals7 trials
Running trials
Recruiting
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Long-term Safety and Tolerability of Iptacopan in Patients With Paroxysmal Nocturnal Hemoglobinuria
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Hidradenitis suppurativa1 recruiting
- Myeloproliferative neoplasms1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 18 Nov 2026